Signal Explorer
Monday, October 19 · 10-K · 10-Q · 8-K · search any ticker above
30
Filings
30
Companies
0
Signals Fired
Amendment Modification Waiver Clause
Top Signal
Trending Classifiers
Other
Erisa Definition Or Compliance Statement
No Broker Fees Representation
Corporate Authority Representation
Form 8K Filing Disclosure
Corporate Organization And Standing Representation
Survival Of Representations Warranties Clause
Non Assignment Clause
Change Of Control Definition
No Regulatory Approval Required
Liquidity Position Snapshot Disclosed
Confidential Information Return Obligation
Market Price Definition
Purchase Price Adjustment Dispute Resolution
Closing Deliverables Specified
Adjusted Ebitda Period Comparison
Other
Institutional Investment
Warrant Valued Black Scholes
Corporate Authority Representation
Use Of Proceeds Disclosure
Transfer And Demand Rights Limitations
Market Price Definition
Closing Deliverables Specified
Ipo Net Proceeds Disclosure
No Broker Fees Representation
Registration Rights Piggyback Provision
Fcpa Compliance Representation
Registrant Bears Registration Expenses
Auditor Appointment Ratification
Conflicted Defense Counsel Provision
Board Committee Member Listing
Business Services
Demand Softening
Other
Share Repurchase Activity Disclosed
Quarterly Loan Deposit Growth Comparison
Allowance For Loan Losses Disclosure
Quarterly Tax Provision Benefit Disclosure
Credit Loss Provision
Interest Income Year Over Year Comparison
Quarterly Dividend Declared
Basel Iii Capital Ratio Requirements Disclosed
Allowance For Credit Losses Methodology Disclosed
Operating Margin Declining
Autocallable Structured Note Offering
Business Services
Demand Softening
Healthcare
Pricing Power Services
SaaS
Membership Growing
Deal Size Increasing
Same Client Revenue Growing
Other
Cost Structure Improving
Market Share Gaining
Effective Tax Rate Reconciliation
Quarterly Loan Deposit Growth Comparison
Allowance For Loan Losses Disclosure
Credit Loss Provision
Quarterly Dividend Declared
Libor Based Term Loan Pricing
Basel Iii Capital Ratio Requirements Disclosed
Competition Disclosure
Other
Restrictive Debt Covenants Disclosure
Libor Based Term Loan Pricing
Investment Grade Rating Defined
Use Of Proceeds Disclosure
Term Loan B Holding Disclosure
Credit Agreement Schedule Amendment
Event Of Default Defined
Other
Rsu Psu Vesting Schedule Disclosed
Say On Pay Vote Result Disclosed
Director Continuity Stated
Quorum Presence Disclosed
Record Date Disclosure
Other
Executive Educational Background Disclosure
Bitcoin Technology Description
Other
Executive Transition Gratitude Statement
Director Continuity Stated
Geographic Footprint Disclosure
Other
Amendment Modification Waiver Clause
New York Jurisdiction Clause
Nyse Listing Disclosure
Registration Rights Piggyback Provision
Warrant Redemption Cashless Exercise Provision
Core
Management Exodus
Other
New York Jurisdiction Clause
Termination For Material Breach Clause
Arbitrator Selection Procedure
Amendment Modification Waiver Clause
Confidential Information Return Obligation
Adea Waiver Release
Cause For Termination Defined
Director Officer Indemnification Provision
Survival Of Representations Warranties Clause
Ip Assignment To Company
Executive Transition Gratitude Statement
Earnings Call Qa Segment
Executive Expense Reimbursement Provision
Executive Severance Change Of Control
Other
Rsu Psu Vesting Schedule Disclosed
Classified Board Director Election
Healthcare
Premium Pricing Power
Reimbursement Improving
Other
Share Repurchase Activity Disclosed
Auto Insurance Premium Growth Disclosure
Ceo Earnings Call Commentary
Unrealized Gain Loss Disclosure
Other
Merger Proxy Statement Disclosure
Adjusted Ebitda Period Comparison
Other
New York Jurisdiction Clause
Ceo Team Pride Statement
Erisa Definition Or Compliance Statement
Corporate Organization And Standing Representation
Share Withholding Tax Settlement
Closing Deliverables Specified
Amendment Modification Waiver Clause
Merger Subsidiary Creation
Survival Of Representations Warranties Clause
Fcpa Compliance Representation
No Broker Fees Representation
Merger Acquisition Synergy Benefit Claim
Confidential Information Return Obligation
Auto Insurance Premium Growth Disclosure
Corporate Authority Representation
Other
Use Of Proceeds Disclosure
Registrant Bears Registration Expenses
Ipo Net Proceeds Disclosure
Registration Rights Piggyback Provision
Other
Confidential Information Return Obligation
Director Officer Indemnification Provision
Goodwill Acquisition Disclosure
Amendment Modification Waiver Clause
New York Jurisdiction Clause
Corporate Authority Representation
Closing Deliverables Specified
Registrant Bears Registration Expenses
Non Assignment Clause
Other
Form 8K Filing Disclosure
Earnings Call Replay Details
Adjusted Ebitda Period Comparison
Free Cash Flow Metric Disclosed
Geographic Footprint Disclosure
Board Committee Member Listing
Healthcare
Utilization Improving
Pricing Power Services
Other
Quarterly Performance Praise
Ceo Earnings Call Commentary
Form 8K Filing Disclosure
Restrictive Debt Covenants Disclosure
Gross Margin Comparison Disclosed
Related Party Loan
Event Of Default Defined
Depreciation Expense Composition Disclosure
Earnings Call Qa Segment
Debt Note Maturity Date Disclosure
Other
Nyse Listing Disclosure
Other
Board Committee Member Listing
Classified Board Director Election
Merger Subsidiary Creation
Nyse Listing Disclosure
Change Of Control Definition
Core
Clinical Trial Result
Indication Expansion
Lead Asset Progress
Clinical Hold
Secondary Endpoint Mentioned
Other
Enrollment Ahead Of Schedule
Fda Aligned
Patient Retention High
Safety Differentiated
Publication Positive
Fast Track Granted
Kol Endorsement
Interim Data Positive
Biotech Risk
Trial Endpoint Missed
Accelerated Approval
No signals above threshold for this filing.
Other
Quorum Presence Disclosed
Merger Proxy Statement Disclosure
Auditor Appointment Ratification
Classified Board Director Election
Other
Kol Endorsement
Fda Aligned
Publication Positive
Enrollment Ahead Of Schedule
Interim Data Positive
Expanded Access Program Active
Core
Clinical Trial Result
Lead Asset Progress
Indication Expansion
Clinical Hold
Secondary Endpoint Mentioned
Other
Institutional Investment
Insider Buying
Convertible Debt Conversion
Core
Management Exodus
Other
Executive Transition Gratitude Statement
Other
Form S3 Shelf Registration Disclosure
Litigation Defense Assertion
Other
Auditor Appointment Ratification
Other
No Broker Fees Representation
Other
Form 8K Filing Disclosure